Benefits of Vitex Agnus-Castus - Vitex and the Menstrual Cycle

Benefits of Vitex Agnus-Castus – Vitex and the Menstrual Cycle

  1. Ryu, A., & Kim, T. H. (2015). Premenstrual syndrome: A mini evaluation.
    Maturitas, 82(4), 436–440.
  2. van Die, M. D., Burger, H. G., Teede, H. J.,
    & Bone, Okay. M. (2013). Vitex agnus-castus extracts for feminine reproductive
    issues: a scientific evaluation of scientific trials. Planta Medica, 79(7),
    562–575.
    3.Treloar, A. E., Boynton, R. E., Behn, B. G., & Brown, B. W.
    (1967). Variation of the human menstrual cycle via reproductive life. Int J
    Fertil, 12(1 Pt 2), 77–126.
  3. Maguire, Okay., & Westhoff, C. (2011). The state
    of hormonal contraception right this moment: established and rising noncontraceptive
    well being advantages. American Journal of Obstetrics and Gynecology, 205(4),
    S4-S8.
  4. Arentz, S., Abbott, J. A., Smith, C. A., & Bensoussan, A. (2014).
    Natural medication for the administration of polycystic ovary syndrome (PCOS) and
    related oligo/amenorrhoea and hyperandrogenism; a evaluation of the laboratory
    proof for results with corroborative scientific findings. BMC Complementary
    and Various Drugs, 14
    (1), 1.
  5. Barr, N. G. (2010). Managing hostile
    results of hormonal contraceptives. American Household Doctor, 82(12).

Kostev, Okay., Rex, J., Eith, T., & Heilmaier, C. (2014). Which hostile results
affect the dropout charge in selective serotonin reuptake inhibitor (SSRI)
therapy? Outcomes for 50,824 sufferers. GMS German Medical Science.
8. Hobbs,
C. (1990). The chaste tree: Vitex agnus castus. Pharmacy in Historical past, 33(1),
19–24.
9. Daniele, C., Thompson Coon, J., & Pittier, M. H. (2005). Vitex
agnus castus: a scientific evaluation of hostile occasions. Drug Saf, 28(4),
319–32.
10. Dietz, B. M., Hajirahimkhan, A., Dunlap, T. L., & Bolton, J. L.
(2016). Botanicals and their bioactive phytochemicals for girls’s well being.
Pharmacological Evaluations, 68(4), 1026–1073.
11. Wuttke, W., Jarry, H.,
Christoffel, V., Spengler, B., & Seidlova-Wuttke, D. (2003). Chaste tree (Vitex
agnus-castus)–pharmacology and scientific indications. Phytomedicine, 10(4),
348–357.
12. Zamani, M., Neghab, N., & Torabian, S. (2012). Therapeutic
impact of Vitex agnus castus in sufferers with premenstrual syndrome. Acta
Medica Iranica, 50
(2), 101.
13. Loch, E. G., Selle, H., & Boblitz, N.
(2000). Therapy of premenstrual syndrome with a phytopharmaceutical
formulation containing Vitex agnus castus. Journal of Girls’s Well being &
Gender-Based mostly Drugs, 9
(3), 315–320.
14. Lauritzen, C. H., Reuter, H. D.,
Repges, R., Böhnert, Okay. J., & Schmidt, U. (1997). Therapy of premenstrual
pressure syndrome with Vitex agnus castus managed, double-blind examine versus
pyridoxine. Phytomedicine, 4(3), 183–189.
15. Schellenberg, R.,
Zimmermann, C., Drewe, J., Hoexter, G., & Zahner, C. (2012). Dose-dependent
efficacy of the Vitex agnus castus extract Ze 440 in sufferers affected by
premenstrual syndrome. Phytomedicine, 19(14), 1325–1331.
16. He, Z., Chen,
R., Zhou, Y., Geng, L., Zhang, Z., Chen, S., … & Lin, S. (2009). Therapy for
premenstrual syndrome with Vitex agnus castus: A potential, randomized,
multi-center placebo managed examine in China. Maturitas, 63(1), 99–103.
17. Momoeda, M., Sasaki, H., Tagashira, E., Ogishima, M., Takano, Y., & Ochiai,
Okay. (2014). Efficacy and security of Vitex agnus-castus extract for therapy of
premenstrual syndrome in Japanese sufferers: a potential, open-label examine.
Advances in Remedy, 31(3), 362–373.
18. Atmaca, M., Kumru, S., & Tezcan,
E. (2003). Fluoxetine versus Vitex agnus castus extract within the therapy of
premenstrual dysphoric dysfunction. Human Psychopharmacology: Medical and
Experimental, 18
(3), 191–195.
19. Ciotta, L., Pagano, I., Stracquadanio,
M., Di Leo, S., Andò, A., & Formuso, C. (2011). Psychic elements of the
premenstrual dysphoric issues. New therapeutic methods: our expertise
with Vitex agnus castus. Minerva Ginecologica, 63(3), 237–245.
20.
Boutzios, G., Karalaki, M., & Zapanti, E. (2013). Frequent pathophysiological
mechanisms concerned in luteal part deficiency and polycystic ovary syndrome.
Affect on fertility. Endocrine, 43(2), 314–317.
21. Jarry, H., Leonhardt,
S., Gorkow, C. H., & Wuttke, W. (1994). In vitro prolactin however not LH and FSH
launch is inhibited by compounds in extracts of Agnus castus: direct proof
for a dopaminergic precept by the dopamine receptor assay. Experimental and
Medical Endocrinology & Diabetes, 102
(6), 448–454.
22. Schück, S.,
Bentué‐Ferrer, D., Kleinermans, D., Reymann, J. M., Polard, E., Gandon, J. M., &
Allain, H. (2002). Psychomotor and cognitive results of piribedil, a dopamine
agonist, in younger wholesome volunteers. Elementary & Medical Pharmacology,
16
(1), 57–65.

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *